Document Detail


Rifampicin and isoniazid in the treatment of leprous nerve abscesses.
MedLine Citation:
PMID:  9259885     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirty nine cases of borderline tuberculoid leprosy having nerve abscesses (15 with sinuses) were treated with daily dose of rifampicin and isoniazid for six months along with standard multidrug therapy. The patients were followed up for three to five years. No recurrence of abscess or sinus was observed. Observations indicate that medical approach is required at times to supplement surgical intervention for management of these cases.
Authors:
S Husain; B Mishra; G N Malaviya
Related Documents :
9473115 - Amebic liver abscess: spare the knife but save the child.
9803235 - Computed tomographic abscessogram: a useful tool for evaluation of percutaneous abscess...
11083215 - Laparoscopic drainage of postoperative complicated intra-abdominal abscesses.
15694825 - Current concepts of percutaneous abscess drainage in postoperative retention.
23242035 - A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph n...
22346455 - Extrapulmonary abscess formation due to pseudomonas cepacia in a cystic fibrosis patient.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta leprologica     Volume:  10     ISSN:  0001-5938     ISO Abbreviation:  Acta Leprol     Publication Date:  1997  
Date Detail:
Created Date:  1997-09-04     Completed Date:  1997-09-04     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0037353     Medline TA:  Acta Leprol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  147-50     Citation Subset:  IM    
Affiliation:
Central Jalma Institute for Leprosy, Tajganj, Agra, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abscess / drug therapy*,  microbiology
Adult
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Isoniazid / therapeutic use*
Leprostatic Agents / therapeutic use*
Leprosy, Borderline / complications*
Leprosy, Tuberculoid / complications*
Male
Nervous System Diseases / drug therapy*,  microbiology
Rifampin / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Leprostatic Agents; 13292-46-1/Rifampin; 54-85-3/Isoniazid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The importance of operational factors for the interpretation of indicators in the Hansen's disease e...
Next Document:  Prevalence of HIV1 in leprosy patients in Rio de Janeiro, Brazil.